Dr Julian Taylor and Ali Gibson

Stoke Mandeville Spinal Research

Dr. Julian Taylor: Julian directs studies focused on sensorimotor dysfunction after spinal cord injury, including spasticity, neuropathic pain and mechanisms of activity based rehabilitation at Stoke Mandeville Spinal Research and at the Hospital Nacional de Parapléjicos in Spain. He is member of the Society for Neuroscience (1990), IASP (2001) and ISCOS (2015).

Ali sustained a spinal cord injury in 1996. She went on to study at the University of Nottingham and graduated in 2006 with a first class honours in Psychology.

Ali is passionate about peer support and maximizing the outcomes of rehabilitation following spinal cord injury and other long-term neurological conditions. She has proven experience of academic and clinical research, clinical trial management, peer support, mentoring and public speaking.

Having first-hand experience of living with the impact of spinal cord injury, Ali is committed to supporting research that aims to improve people’s quality of life following spinal cord injury. In her current position as Community Liaison Officer for Stoke Mandeville Spinal Research (SMSR), she works closely with key stakeholders and in the community to raise awareness of living with spinal cord injury and to discuss the research that that is being undertaken by SMSR.

dont miss

Spinal Cord Injury Spasticity: a research update on symptoms

Spasticity is an important sensorimotor disorder that affects more than 60% of people with spinal cord injury (SCI). Although the standard diagnosis of the SCI spasticity syndrome has traditionally relied on the measurement of muscle rigidity, the assessment of other symptoms such as involuntary muscle spasms and cutaneous hyperreflexia may also provide an insight into how spasticity can affect residual motor function and activities of daily life (ADL). In this lecture the importance of characterising different spasticity symptoms in relation to understanding their negative and positive impact on residual neuromuscular function will be discussed. The impact of SCI symptoms on neuromuscular function and ADL will also be described by our Community Liaison Officer who has first-hand experience of spasticity. Finally, the possibilities of how new neurorehabilitation technologies can contribute to the management of spasticity symptoms will be also be discussed.

EVEN MORE SEMINARS

  • Dr Cheryl Metcalf: Speaking at the European Neurological Convention

    Dr Cheryl Metcalf
    University of Southampton

    Commericalising health technologies

  • Andrew Fahey: Speaking at the European Neurological Convention

    Andrew Fahey
    Brookson Direct

    The Impact of IR35 on the NHS

  • Bethel Osuagwu, Derek Jones: Speaking at the European Neurological Convention

    Bethel Osuagwu, Derek Jones
    Stoke Mandeville Spinal Research

    Assessment of the orthotic and long-term functional gain of the SEM Glove in people with chronic spinal cord injury

  • Dr Anne Wright: Speaking at the European Neurological Convention

    Dr Anne Wright
    Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS foundation Trust

    Neuromodulation for Incontinence in Children

  • Dr Julian Taylor, Miguel Rodriguez, Dr. Armin Schnürer: Speaking at the European Neurological Convention

    Dr Julian Taylor, Miguel Rodriguez, Dr. Armin Schnürer
    Gtec & Advanced Medical Equipment

    The DolSCI Network: Harnessing Expertise for Better Neuropathic Pain Control